Developing World Access To Medication: “Access to life-saving, essential medicines must be improved,” Josh Ruxin, founder and director of the Access Project and director of Rwanda Works,Â writes in a Forbes’ “Science Business” blog. After looking at the debate over whether the free market can help improve access and examining programs,…
The New York Times examines several products being studied in clinical trials that researchers hope will one day prevent sexual transmission of HIV. The newspaper describes the ongoing trials of a vaginal microbicide gel containing the antiretroviral tenofovir which was found to reduce the risk of HIV infection in women by 39 percent, writing, “[o]ther clinical trials will report their results in 2011 and 2012 and, if all goes well, researchers hope to have a product or two ready to enter the market by 2013.”
“Central and Eastern Europe is facing ‘significant challenges’ in combating a multi-billion euro, and often lethal, trade in fake medicines, security and pharmaceutical groups have warned,” Inter Press Service reports in an article that examines the scope of the problem in a region now “identified as a key smuggling route in an illicit trade which is growing every year.”
Also In Global Health News: Flooding, HIV Treatment Adherence, and Economic Growth In Africa; China Detects Superbug; U.S. Aid To Myanmar; Cash-Transfer Programs
1.8M Now Affected By Flooding In West And Central Africa; Hardest Hit-Benin Struggles With Disease, Damaged Health Centers Flooding continues to devastate Central and West AfricaÂ â€“ more than 1.8 million people have been affected and 400 killed, according to the U.N., United Press International reports. “The nation of Benin has…
Also In Global Health News: Foreign Aid In Ethiopia; Elizabeth Glaser Pediatric AIDS Foundation; Health In Myanmar; Poverty In Zambia; Rwanda’s Progress on MDGs; Men Involved In PMTCT Of HIV
Ethiopian Government Restricting Opponents’ Access To Development Aid, Report Says Ethiopia’s government has beenÂ restricting access toÂ food and other types of foreign aid among opposition supporters, Human Rights Watch (HRW) said in a report on Tuesday, Reuters reports (Malone, 10/19). The report is based on more than 200 interviews, conducted over…
Also In Global Health News: Drug-Resistance Gene; Polio In Nigeria; Dengue Vaccine; River Blindness Diagnostic Test
Newspaper Examines Gene That Enables Drug Resistance In Bacteria The Washington Post looks at the gene NDM-1, which makes bacteria “resistant to many medications [and] marks a worrying development in the fight against infectious diseases, which can mutate to defeat humans’ antibiotic arsenal.” The article examines the presumed origin of…
The NIH announced Thursday “it will share intellectual property rights on some AIDS drugs in a patent pool designed to make treatments more widely available to the poor,” Reuters reports. The move makes the NIH the “the first research institution to join an HIV medicines patent pool launched by UNITAID, a health financing system funded by a tax on airline tickets which was co-founded by Brazil, Britain, Chile, France, and Norway in 2006,” the news service adds (Kelland, 9/30).
Efforts Against Drug-Resistant Malaria Along Thai-Cambodian Border Show Progress, But More ‘Aggressive’ Approach Needed, Health Officials Say
Efforts to prevent the spread of drug-resistant malaria along the border between Cambodia and Thailand are showing signs of progress, but additional work is needed to contain the new strain, health officials said on Friday, Deutsche Presse-Agentur/M&C reports.
Also In Global Health News: Generic Drugs From India; Rapid TB Test; U.S.-India Agriculture Dialogue; Zimbabwe’s Health Sector; ‘Superbug’ In U.S.
Changing Trade Rules In India Could Impede Access To Generic Drugs Generic drugs produced in India “could cost more and be harder to access if the country has to adhere to stricter intellectual property rules,” Reuters reports, noting that the country supplies the “bulk” of AIDS medicines that go developing…
The 50th annual meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) kicked off in Boston on Sunday with experts warning that a “slowdown” in research on antibiotic development could result in treatment challenges, Agence France-Presse reports.